BioSpectrum Asia Magazine - December 2021
BioSpectrum Asia Magazine - December 2021
Go Unlimited with Magzter GOLD
Read BioSpectrum Asia along with 8,500+ other magazines & newspapers with just one subscription View catalog
1 Month $9.99
1 Year$99.99
$8/month
Subscribe only to BioSpectrum Asia
1 Year$11.88 $7.99
Buy this issue $0.99
In this issue
Focusing on VIGILANCE & PREPAREDNESS
Despite advances in development of countermeasures such as diagnostics, therapeutics and vaccines, world travel and increased global interdependence have added layers of complexity to containing infectious diseases. COVID-19, an outcome of weaponisation by genetic manipulation as part of ‘gain of function’ research, had brought the entire world to its knees in less than six months. Now, researchers and policymakers are being more vigilant towards surveillance and management of emerging infectious disease threats, and revisit global mechanisms for the control of pandemic disease. In addition to other countries across the globe, 2021 saw many initiatives taken by the APAC region to strengthen their capacities for effective preparedness and for the prevention of new and existing infectious diseases.
India launches Ayushman Bharat Health Infrastructure Mission
The Prime Minister said that there are three major aspects of the Ayushman Bharat Health Infrastructure Mission to address the different gaps in the health sector of the country.
1 min
Hong Kong provides $3M for Sydney health hub
A global collaboration to apply data science and artificial intelligence (AI) methods to solve intractable problems in public health has been launched simultaneously in Sydney and Hong Kong (HK).
1 min
Cipla launches India's first pneumotach-based wireless spirometer
Cipla’s Spirofy is a result of five years of in-house research by the Integrated Product Development (IPD) team, and it aims to transform OAD diagnosis in India.
1 min
Holborn Wells, SpeedBio India JV to invest $1M for IVD manufacturing
SpeedBio is one of the leading IVD promoters in the region with a team of former executives from leading diagnostics and healthcare companies such as Siemens and CORE Diagnostics.
1 min
Who Covid-19 Solidarity Trial Picks Taiwan's Medigen's Vaccine
Taiwan’s Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation advisory group to be included in the World Health Organisation (WHO) Solidarity Trial Vaccines (STv).
1 min
Focusing on VIGILANCE & PREPAREDNESS
Despite advances in development of countermeasures such as diagnostics, therapeutics and vaccines, world travel and increased global interdependence have added layers of complexity to containing infectious diseases.
10+ mins
Reality of Universal Cancer Prevention & Cure
Oncology is the largest pharmaceutical therapeutic area, and big pharma is investing billions of dollars in search of the elusive cancer cure. With all this investment and innovation, will we ever see a universal cancer cure? Let’s find out.
8 mins
“Uptick in public & private investors is enabling standalone companies”
Swiss biotech venture accelerator and incubator BaseLaunch was started in 2017 to help launch and grow the next generation of biotech companies. The accelerator has already financed 16 startups and most of them have raised series A funding.
4 mins
“Our goal is to decouple process from the product”
Waters Corporation, a world leader in analytical technologies, has recorded sales of $1,949 million, an increase of 23 per cent for the first nine months of 2021, compared to sales of $1,579 million for the first nine months of 2020.
9 mins
Vaccine Immunology — Potentially the Biggest Game Changer in Asian Healthcare
There is a common pearl of Indian wisdom that encourages parents to let their children play outside in the sun, rain, gardens and mud. The premise is that it allows children to grow closer to nature and natural elements, but it also helps them build immunity and become tough. In modern science, various medical research has reported the benefits of environmental exposure in early childhood for developing immunity.
5 mins
BioSpectrum Asia Magazine Description:
Publisher: MM Activ Sci-Tech Communication
Category: Business
Language: English
Frequency: Monthly
BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:
* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.
BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.
- Cancel Anytime [ No Commitments ]
- Digital Only